Fadia T. Shaya - Publications

Affiliations: 
Pharmaceutical Health Services Research University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Epidemiology, Medicine and Surgery, Public Health

108 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Chirikov VV, Shaya FT, Onukwugha E, Mullins CD, dosReis S, Howell CD. Tree-based Claims Algorithm for Measuring Pretreatment Quality of Care in Medicare Disabled Hepatitis C Patients. Medical Care. 55: e104-e112. PMID 29135773 DOI: 10.1097/MLR.0000000000000405  0.48
2016 Khanna N, Shaya FT, Gaitonde P, Abiamiri A, Steffen B, Sharp D. Evaluation of PCMH Model Adoption on Teamwork and Impact on Patient Access and Safety. Journal of Primary Care & Community Health. PMID 27838621 DOI: 10.1177/2150131916678496  0.48
2016 Khanna N, Shaya FT, Chirikov VV, Sharp D, Steffen B. Impact of Case Mix Severity on Quality Improvement in a Patient-centered Medical Home (PCMH) in the Maryland Multi-Payor Program. Journal of the American Board of Family Medicine : Jabfm. 29: 116-25. PMID 26769883 DOI: 10.3122/jabfm.2016.01.150067  0.48
2016 Khanna N, Shaya FT, Chirikov VV, Sharp D, Steffen B. Impact of case mix severity on quality improvement in a patient-centered medical home (PCMH) in the Maryland multi-payor program Journal of the American Board of Family Medicine. 29: 116-125. DOI: 10.3122/jabfm.2016.01.150067  1
2015 Wickwire EM, Shaya FT, Scharf SM. Health economics of insomnia treatments: The return on investment for a good night's sleep. Sleep Medicine Reviews. 30: 72-82. PMID 26874067 DOI: 10.1016/j.smrv.2015.11.004  1
2015 Chirikov VV, Shaya FT, Mullins CD, dosReis S, Onukwugha E, Howell CD. Determinants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis C. Expert Review of Gastroenterology & Hepatology. 9: 1447-62. PMID 26524244 DOI: 10.1586/17474124.2015.1095087  0.48
2015 Kountz DS, Shaya FT, Gradman AH, Puckrein GA, Kim MH, Wilbanks J, Stevenson JG, Larsen DL, Wysong M, Chirikov V, Pan WT, Xu L. A Call for Appropriate Evidence and Outcomes-Based Use and Measurement of Anticoagulation for Atrial Fibrillation: Moving the Population Towards Improved Health Via Multiple Stakeholders. Journal of Managed Care & Specialty Pharmacy. 21: 1034-8. PMID 26521115  1
2015 Chirikov VV, Shaya FT, Onukwugha E, Mullins CD, dosReis S, Howell CD. Tree-based Claims Algorithm for Measuring Pretreatment Quality of Care in Medicare Disabled Hepatitis C Patients. Medical Care. PMID 26225448 DOI: 10.1097/MLR.0000000000000405  0.48
2015 Shaya FT, Chirikov VV, Rochester C, Zaghab RW, Kucharski KC. Impact of a comprehensive pharmacist medication-therapy management service. Journal of Medical Economics. 18: 828-37. PMID 25985395 DOI: 10.3111/13696998.2015.1052463  1
2015 Shaya FT, Breunig IM, Mehra MR. Disease-modifying therapy and hospitalization risk in heart failure patients. The American Journal of Managed Care. 21: 39-47. PMID 25880149  1
2015 Chirikov VV, Shaya FT, Howell CD. Contextual analysis of determinants of late diagnosis of hepatitis C virus infection in medicare patients. Hepatology (Baltimore, Md.). 62: 68-78. PMID 25754171 DOI: 10.1002/hep.27775  1
2015 Breunig IM, Shaya FT, Tevie J, Roffman D. Incident depression increases medical utilization in Medicaid patients with hypertension. Expert Review of Cardiovascular Therapy. 13: 111-8. PMID 25487173 DOI: 10.1586/14779072.2014.969712  1
2015 Tevie J, Shaya FT. Association between mental health and comorbid obesity and hypertension among children and adolescents in the US. European Child & Adolescent Psychiatry. 24: 497-502. PMID 25146327 DOI: 10.1007/s00787-014-0598-8  1
2015 Chirikov VV, Mullins CD, Hanna N, Breunig IM, Seal B, Shaya FT. Multispecialist Care and Mortality in Hepatocellular Carcinoma. American Journal of Clinical Oncology. 38: 557-63. PMID 24064759 DOI: 10.1097/COC.0000000000000000  0.48
2015 Chirikov VV, Shaya FT, Mullins CD, Dosreis S, Onukwugha E, Howell CD. Determinants of quality of care and treatment initiation in Medicare disabled patients with chronic hepatitis C Expert Review of Gastroenterology and Hepatology. 9: 1447-1462. DOI: 10.1586/17474124.2015.1095087  1
2015 Chirikov VV, Mullins CD, Hanna N, Breunig IM, Seal B, Shaya FT. Multispecialist care and mortality in hepatocellular carcinoma American Journal of Clinical Oncology: Cancer Clinical Trials. 38: 557-563. DOI: 10.1097/COC.0000000000000000  1
2014 Breunig IM, Shaya FT, McPherson ML, Snitker S. Development of heart failure in Medicaid patients with type 2 diabetes treated with pioglitazone, rosiglitazone, or metformin. Journal of Managed Care & Specialty Pharmacy. 20: 895-903. PMID 25166288  1
2014 Chirikov VV, Shaya FT, Howell CD. Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis C. Expert Review of Gastroenterology & Hepatology. 8: 973-83. PMID 25109401 DOI: 10.1586/17474124.2014.945911  1
2014 Johnson W, Shaya FT, Winston R, Laird A, Mullins CD, Chirikov VV, Saunders E. Diabetes control through an educational intervention. Ethnicity & Disease. 24: 182-8. PMID 24804364  1
2014 Desai B, Freeman E, Huang E, Hung A, Knapp E, Breunig IM, McPherson ML, Shaya FT. Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy. Expert Review of Clinical Pharmacology. 7: 203-9. PMID 24524594 DOI: 10.1586/17512433.2014.889562  1
2014 Shaya FT, Chirikov VV, Howard D, Foster C, Costas J, Snitker S, Frimpter J, Kucharski K. Effect of social networks intervention in type 2 diabetes: a partial randomised study. Journal of Epidemiology and Community Health. 68: 326-32. PMID 24297971 DOI: 10.1136/jech-2013-203274  1
2014 Shaya FT, Breunig IM, Seal B, Mullins CD, Chirikov VV, Hanna N. Comparative and cost effectiveness of treatment modalities for hepatocellular carcinoma in SEER-medicare Pharmacoeconomics. 32: 63-74. PMID 24293197 DOI: 10.1007/s40273-013-0109-7  1
2014 Greenberg-Dotan S, Reuveni H, Tal A, Oksenberg A, Cohen A, Shaya FT, Tarasiuk A, Scharf SM. Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea. Sleep & Breathing = Schlaf & Atmung. 18: 69-75. PMID 23733255 DOI: 10.1007/s11325-013-0850-3  1
2013 Breunig IM, Shaya FT, Hanna N, Seal B, Chirikov VV, Daniel Mullins C. Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 16: 760-8. PMID 23947969 DOI: 10.1016/j.jval.2013.03.1630  1
2013 Shaya FT, Chirikov VV, Bron M, Howard D, Foster C, Yan X, Khanna N, Warrington VO. Comparison of physician practice patterns for older adults compared to NHANES diabetes cohort on oral/other therapy. Expert Review of Pharmacoeconomics & Outcomes Research. 13: 153-60. PMID 23402455 DOI: 10.1586/erp.12.75  1
2013 Shaya FT, Chirikov VV, Daniel Mullins C, Shematek J, Howard D, Foster C, Saunders E. Social networks help control hypertension. Journal of Clinical Hypertension (Greenwich, Conn.). 15: 34-40. PMID 23282122 DOI: 10.1111/jch.12036  1
2012 Shaya FT, Breunig IM, Mullins CD, Pandya NB, Chirikov V, Seal BS, Hanna N. Comparative analysis of treatments, utilization, and survival benefit in HCC patients: A real-world analysis of SEER Medicare. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 214. PMID 27983216 DOI: 10.1200/jco.2012.30.4_suppl.214  0.48
2012 Shaya FT, Breunig IM, Hanna N, Pandya NB, Chirikov V, Seal BS, Mullins CD. Is the number of TACE treatments in HCC patients associated with improved survival? A SEER-Medicare population analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 210. PMID 27983200 DOI: 10.1200/jco.2012.30.4_suppl.210  0.48
2012 Breunig IM, Shaya FT, Scharf SM. Delivering cost-effective care for COPD in the USA: recent progress and current challenges. Expert Review of Pharmacoeconomics & Outcomes Research. 12: 725-31. PMID 23252355 DOI: 10.1586/erp.12.69  1
2012 Mullins CD, Shaya FT, Blatt L, Saunders E. A qualitative evaluation of a citywide Community Health Partnership program. Journal of the National Medical Association. 104: 53-60. PMID 22708248  1
2012 Shaya FT, Breunig IM, Scharf SM. The use of age-period-cohort analysis to determine the impact of economic development on COPD mortality in Hong Kong. Expert Review of Pharmacoeconomics & Outcomes Research. 12: 19-21. PMID 22280192 DOI: 10.1586/erp.11.101  1
2012 Gliklich R, Glennie J, Mattox PW, Graff JS, Garner S, Marrone CM, Shaya FT, Hansen J, Lewin J, Blackburn S, Berger M, Dreyer NA. Survey of Real-World Research Workforce, Training, and Education: Report from the DIA Real-World Outcomes Task Force Drug Information Journal. 46: 185-191. DOI: 10.1177/0092861512437760  1
2011 Shaya FT, Gbarayor CM, Laird A, Winston R, Saunders E. Diabetes knowledge in a high risk urban population. Ethnicity & Disease. 21: 485-9. PMID 22428355  1
2011 Shaya FT, Chirikov VV. Decision support tools to optimize economic outcomes for type 2 diabetes. The American Journal of Managed Care. 17: S377-83. PMID 22214425  1
2011 Johnson W, Shaya FT, Khanna N, Warrington VO, Rose VA, Yan X, Bailey-Weaver B, Mullins CD, Saunders E. The Baltimore Partnership to Educate and Achieve Control of Hypertension (The BPTEACH Trial): a randomized trial of the effect of education on improving blood pressure control in a largely African American population. Journal of Clinical Hypertension (Greenwich, Conn.). 13: 563-70. PMID 21806766 DOI: 10.1111/j.1751-7176.2011.00477.x  1
2011 Onwudiwe NC, Mullins CD, Winston RA, Shaya FT, Pradel FG, Laird A, Saunders E. Barriers to self-management of diabetes: a qualitative study among low-income minority diabetics. Ethnicity & Disease. 21: 27-32. PMID 21462726  1
2011 Onukwugha E, Mullins CD, Loh FE, Saunders E, Shaya FT, Weir MR. Readmissions after unauthorized discharges in the cardiovascular setting. Medical Care. 49: 215-24. PMID 21206297 DOI: 10.1097/MLR.0b013e31820192a5  1
2010 Shaya FT, Yan X, Farshid M, Barakat S, Jung M, Low S, Fedder D. Social networks in cardiovascular disease management. Expert Review of Pharmacoeconomics & Outcomes Research. 10: 701-5. PMID 21155703 DOI: 10.1586/erp.10.68  1
2010 Shaya FT, Yan X, Lin PJ, Simoni-Wastila L, Bron M, Baran R, Donner TW. US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes. Journal of Clinical Hypertension (Greenwich, Conn.). 12: 826-32. PMID 21029348 DOI: 10.1111/j.1751-7176.2010.00365.x  1
2010 Bivins A, Hou K, Ayesu N, Ellsworth B, Montenegro S, Tu X, Boyle C, Dowling T, Shaya FT. Clinical evaluation of natalizumab for formulary consideration. Expert Opinion On Biological Therapy. 10: 1279-87. PMID 20626228 DOI: 10.1517/14712598.2010.505234  1
2010 Brandes DW, Shaya FT, Pill MW. Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis. The American Journal of Managed Care. 16: S171-7. PMID 20615053  1
2010 Bakhshai J, Bleu-Lainé R, Jung M, Lim J, Reyes C, Sun L, Rochester C, Shaya FT. The cost effectiveness and budget impact of natalizumab for formulary inclusion. Journal of Medical Economics. 13: 63-9. PMID 20028199 DOI: 10.3111/13696990903543424  1
2010 Lin PJ, Shaya FT, Scharf SM. Economic implications of comorbid conditions among Medicaid beneficiaries with COPD. Respiratory Medicine. 104: 697-704. PMID 19954941 DOI: 10.1016/j.rmed.2009.11.009  1
2009 Shaya FT, Lu Z, Sohn K, Weir MR. Thiazolidinediones and cardiovascular events in high-risk patients with type-2 diabetes mellitus: a comparison with other oral antidiabetic agents. P & T : a Peer-Reviewed Journal For Formulary Management. 34: 490-501. PMID 20140111  0.32
2009 Blanchette CM, Simoni-Wastila L, Shaya FT, Orwig D, Noel J, Stuart B. Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality. Cardiology Research and Practice. 2009: 194528. PMID 20069046 DOI: 10.4061/2009/194528  0.36
2009 Shaya FT, Low S, Barakat S, Farshid M, Jung M, Norman N, Fedder DO. Case for a pharmacy-centered medical home. Expert Review of Pharmacoeconomics & Outcomes Research. 9: 397-9. PMID 19817521 DOI: 10.1586/erm.09.27  1
2009 Onukwugha EC, Shaya FT, Saunders E, Weir MR. Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease. Ethnicity & Disease. 19: 172-8. PMID 19537229  1
2009 Shaya FT, Lin PJ, Aljawadi MH, Scharf SM. Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome. Sleep & Breathing = Schlaf & Atmung. 13: 317-23. PMID 19484281 DOI: 10.1007/s11325-009-0266-2  1
2009 Shaya FT, Maneval MS, Gbarayor CM, Sohn K, Dalal AA, Du D, Scharf SM. Burden of COPD, asthma, and concomitant COPD and asthma among adults: racial disparities in a medicaid population. Chest. 136: 405-11. PMID 19318663 DOI: 10.1378/chest.08-2304  1
2009 Shaya FT, Du D, Gbarayor CM, Frech-Tamas F, Lau H, Weir MR. Predictors of compliance with antihypertensive therapy in a high-risk medicaid population. Journal of the National Medical Association. 101: 34-9. PMID 19245070  1
2009 Blak BT, Mullins CD, Shaya FT, Simoni-Wastila L, Cooke CE, Weir MR. Prescribing trends and drug budget impact of the ARBs in the UK. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 12: 302-8. PMID 18647253 DOI: 10.1111/j.1524-4733.2008.00423.x  1
2009 Onukwugha EC, Shaya FT, Saunders E, Weir MR. Ethnic disparities, hospital quality, and discharges against medical advice among patients with cardiovascular disease (Ethnicity & Disease (2009) 19, (172-178)) Ethnicity and Disease. 19: 375.  1
2009 Robertson TA, Cooke CE, Wang JJ, Shaya FT, Lee HY. Concern still warranted: Medication burden and persistence with lipid-lowering drugs - Reply American Journal of Managed Care. 15: 75.  1
2008 Shaya FT, Du D, Frech-Tamas F, Lau H, Fatodu H, Garber H. Predictors of fixed-dose combination antihypertensive drug therapy in a Medicaid population. Journal of the American Society of Hypertension : Jash. 2: 469-75. PMID 20409928 DOI: 10.1016/j.jash.2008.04.011  1
2008 Shaya FT, Gu A, Yan X. Effect of Persistence with Drug Therapy On the Risk of Myocardial Re-infarction. P & T : a Peer-Reviewed Journal For Formulary Management. 33: 288-95. PMID 19561792  1
2008 Robertson TA, Cooke CE, Wang J, Shaya FT, Lee HY. Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension. The American Journal of Managed Care. 14: 710-6. PMID 18999905  1
2008 Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, Dalal A, Scharf SM. Burden of concomitant asthma and COPD in a Medicaid population. Chest. 134: 14-9. PMID 18339789 DOI: 10.1378/chest.07-2317  1
2008 Shaya FT, Flores D, Gbarayor CM, Wang J. School-based obesity interventions: a literature review. The Journal of School Health. 78: 189-96. PMID 18336677 DOI: 10.1111/j.1746-1561.2008.00285.x  1
2007 Shaya FT, Gu A, Saunders E. Metabolic Syndrome Prevalence in an Urban African American Population. Diabetes & Metabolic Syndrome. 1: 151-157. PMID 28194239 DOI: 10.1016/j.dsx.2007.05.003  0.64
2007 Shaya FT, Samant N, Pradel F, Mullins CD, Scharf SM, Britt J. Health-related quality of life as a potential predictor in chronic obstructive lung disease patients. Expert Review of Pharmacoeconomics & Outcomes Research. 7: 129-35. PMID 20528439 DOI: 10.1586/14737167.7.2.129  1
2007 Wang J, Zuckerman IH, Miller NA, Shaya FT, Noel JM, Mullins CD. Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Health Services Research. 42: 1499-519. PMID 17610435 DOI: 10.1111/j.1475-6773.2006.00682.x  1
2007 Wang J, Mullins CD, Mamdani M, Rublee DA, Shaya FT. New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study. The Annals of Pharmacotherapy. 41: 937-43. PMID 17488830 DOI: 10.1345/aph.1H659  1
2007 Shaya FT, Ohsfeldt RL. Bridging the gap between pharmacoeconomics and the real-world practice of managed care pharmacy. Journal of Managed Care Pharmacy : Jmcp. 13: 66-7. PMID 17269839 DOI: 10.18553/jmcp.2007.13.1.66  1
2007 Shaya FT, Gbarayor CM, Huiwen Keri Yang, Agyeman-Duah M, Saunders E. A perspective on African American participation in clinical trials. Contemporary Clinical Trials. 28: 213-7. PMID 17141575 DOI: 10.1016/j.cct.2006.10.001  1
2007 Shaya FT, Sohn K, Lee S, Bleu-Laine R, Lim J, Casciano M. Clinical and economic evaluation of exenatide for formulary decisions Journal of Medical Economics. 10: 529-537. DOI: 10.3111/13696990701748415  1
2007 Shaya FT, Gu A, Saunders E. Metabolic syndrome prevalence in an urban African American population Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 1: 151-157. DOI: 10.1016/j.dsx.2007.05.003  1
2007 Shaya FT, Gu A. Critical assessment of intent-to-treat analyses Journal of Medical Economics. 10: 171-177.  1
2007 Shaya FT, Wang J, Casciano M, Lee S, Levine A, Varghese R. Clinical and economic evaluation of olanzapine-fluoxetine HCl combination in the treatment of bipolar depression: A managed care approach Journal of Medical Economics. 10: 67-77.  1
2006 Shaya FT, Gbarayor C. Adjusting for risk and confounding in outcomes research. Expert Review of Pharmacoeconomics & Outcomes Research. 6: 109-10. PMID 20528544 DOI: 10.1586/14737167.6.2.109  1
2006 Shaya FT, Gu A. Deriving effectiveness information for decision-making. Expert Review of Pharmacoeconomics & Outcomes Research. 6: 5-7. PMID 20528530 DOI: 10.1586/14737167.6.1.5  1
2006 Shaya FT, Gbarayor CM. The case for cultural competence in health professions education. American Journal of Pharmaceutical Education. 70: 124. PMID 17332850  1
2006 Wang J, Noel JM, Zuckerman IH, Miller NA, Shaya FT, Mullins CD. Disparities in access to essential new prescription drugs between non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Medical Care Research and Review : McRr. 63: 742-63. PMID 17099124 DOI: 10.1177/1077558706293638  1
2006 Mullins CD, Kuznik A, Shaya FT, Obeidat NA, Levine AR, Liu LZ, Wong W. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Clinical Therapeutics. 28: 1184-98. PMID 16982296 DOI: 10.1016/j.clinthera.2006.08.016  1
2006 Shaya FT, El Khoury AC, Mullins CD, Du D, Skolasky R, Fatodu H, Garber H, Weir MR. Drug therapy persistence and stroke recurrence. The American Journal of Managed Care. 12: 313-9. PMID 16756450  1
2006 Shaya FT, Deshpande G. New treatment approaches to diabetes. Managed Care (Langhorne, Pa.). 15: 38, 40-1. PMID 16749518  1
2006 Mullins CD, Shaya FT, Meng F, Wang J, Bron MS. Comparison of first refill rates among users of sertraline, paroxetine, and citalopram. Clinical Therapeutics. 28: 297-305; discussion . PMID 16678651 DOI: 10.1016/j.clinthera.2006.02.006  1
2006 Shaya FT, Gu A, Saunders E. Addressing cardiovascular disparities through community interventions. Ethnicity & Disease. 16: 138-44. PMID 16599362  1
2006 Mullins CD, Shaya FT, Zito JM, Obeidat N, Naradzay J, Harrison DJ. Effect of initial ziprasidone dose on treatment persistence in schizophrenia. Schizophrenia Research. 83: 277-84. PMID 16545945 DOI: 10.1016/j.schres.2006.01.013  1
2006 Shaya FT, El Khoury AC, Samant ND, Scharf SM. Utilization of health care resources in a high-risk medicaid population with chronic obstructive pulmonary disease P and T. 31: 261-268.  1
2006 Shaya FT, Yi G, El Khoury AC, Lee S, Calloway S, Levine A. Clinical and economic considerations for teriparatide: A managed care approach Journal of Drug Assessment. 9: 3-13.  1
2006 Shaya FT, El Khoury AC, Wong W, Whitelaw N, Whitelaw G, Joseph RE, Cohen RD. Persistence with pharmacotherapy for gastrointestinal disease: Associated costs of health care P and T. 31: 657-665.  1
2005 Shaya FT, Klaskala W, Mullins CD. Review of cost-effectiveness studies of pegylated therapies for hepatitis C. Expert Review of Pharmacoeconomics & Outcomes Research. 5: 339-51. PMID 19807603 DOI: 10.1586/14737167.5.3.339  1
2005 Shaya FT, El Khoury AC. Developing benchmarks for adherence studies. Expert Review of Pharmacoeconomics & Outcomes Research. 5: 229-32. PMID 19807591 DOI: 10.1586/14737167.5.3.229  1
2005 Shaya FT, Samant N, Skolasky R, Saunders E. Modeling risk of gastrointestinal events among Medicaid NSAID users using propensity scores. Expert Review of Pharmacoeconomics & Outcomes Research. 5: 625-32. PMID 19807588 DOI: 10.1586/14737167.5.5.625  1
2005 Shaya FT. The burden of obstructive lung disease in Medicaid and managed care populations. Managed Care (Langhorne, Pa.). 14: 20-3; discussion 24-. PMID 18564561  1
2005 Shaya FT. Compliance with medicine. Ophthalmology Clinics of North America. 18: 611-7. PMID 16314223 DOI: 10.1016/j.ohc.2005.07.005  1
2005 Shaya FT, Blume S, Gu A, Zyczynski T, Jumadilova Z. Persistence with overactive bladder pharmacotherapy in a Medicaid population. The American Journal of Managed Care. 11: S121-9. PMID 16161385  1
2005 Shaya FT, Gu A. Assessing potential risks and evaluating expected benefits. Managed Care Interface. 18: 27-30. PMID 15941187  1
2005 Mullins CD, Shaya FT, Meng F, Wang J, Harrison D. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Pharmacotherapy. 25: 660-7. PMID 15899727 DOI: 10.1592/phco.25.5.660.63590  1
2005 Shaya FT, Shin JY, Mullins D, Fatodu HO, Gu A, Saunders E. Medicaid managed care: disparities in the use of thiazolidinediones compared with metformin. Journal of the National Medical Association. 97: 493-7. PMID 15868769  1
2005 Shaya FT, Blume S. Prescriptions for cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory agents in a medicaid managed care population: African Americans versus Caucasians. Pain Medicine (Malden, Mass.). 6: 11-7. PMID 15669946 DOI: 10.1111/j.1526-4637.2005.05011.x  1
2005 Shaya FT, Blume SW, Blanchette CM, Weir MR, Mullins CD. Selective cyclooxygenase-2 inhibition and cardiovascular effects: An observational study of a medicaid population Archives of Internal Medicine. 165: 181-186. PMID 15668364 DOI: 10.1001/archinte.165.2.181  1
2005 Shaya FT, Kim J. Editorial comment: Off-label use is a common though underexamined practice Drug Benefit Trends. 17: 27.  1
2005 El Khoury A, Shaya FT. Editorial comment: Medicare HMOs associated with improved diabetes outcomes Drug Benefit Trends. 17: 304.  1
2005 Shaya FT, Calloway S, El Khoury AC, Tomety J. Clinical and economic evaluation of two thiazolidinediones in the management of diabetes P and T. 30: 456-460.  1
2005 Shaya FT, Shin JY, Mullins CD, El Khoury AC, Garber H. Risk of heart failure with the use of thiazolidinediones within a medicaid population P and T. 30: 273-281.  1
2004 Shaya FT, Samant N. Formulary decision methodology in the context of health system costs and insurance trends. Expert Review of Pharmacoeconomics & Outcomes Research. 4: 595-7. PMID 19807530 DOI: 10.1586/14737167.4.6.595  1
2004 Shaya FT, Samant N. Cost studies in clinical trials. Expert Review of Pharmacoeconomics & Outcomes Research. 4: 591-4. PMID 19807529 DOI: 10.1586/14737167.4.6.591  1
2004 Shaya FT, Shin JY, Wong WI, Proveaux W. Clinical and economic evaluation of gatifloxacin and levofloxacin. Expert Review of Pharmacoeconomics & Outcomes Research. 4: 469-77. PMID 19807305 DOI: 10.1586/14737167.4.4.469  1
2004 Shaya FT, Wong W, Shin JY, Martin L, Samant N. Formulary decision-making considerations: COX-2 inhibitors. Managed Care Interface. 17: 29-36, 41. PMID 15573802  1
2004 Shaya FT, Blume S, Mullins CD. Prescription drug spending trends for the privately insured in Maryland, 2000-2001. Health Affairs (Project Hope). 23: 226-32. PMID 15371389 DOI: 10.1377/hlthaff.23.5.226  1
2004 Mullins CD, Cooke JL, Wang J, Shaya FT, Hsu DV, Brooks S. Disparities in prevalence rates for lung, colorectal, breast, and prostate cancers in Medicaid. Journal of the National Medical Association. 96: 809-16. PMID 15233491  1
2004 Mullins CD, Shaya FT, Flowers LR, Saunders E, Johnson W, Wong W. Health care cost of analgesic use in hypertensive patients. Clinical Therapeutics. 26: 285-93. PMID 15038951 DOI: 10.1016/S0149-2918(04)90027-6  1
2004 Shaya FT, Blume SW, Blanchette CM, Mullins CD, Foster S. Propensity to prescribe COX-2 inhibitors vs other NSAIDs in a Medicaid MCO Formulary. 39: 320-321.  1
2003 Mullins CD, Ndiritu EM, Yoder DM, Shaya FT, Taylor TA. Impact of the fourth hurdle on the international pharmaceutical industry. Expert Review of Pharmacoeconomics & Outcomes Research. 3: 169-77. PMID 19807364 DOI: 10.1586/14737167.3.2.169  1
2003 Shaya FT. Summary quality scores for pharmacoeconomic studies: balancing validity with need. Journal of Managed Care Pharmacy : Jmcp. 9: 87-8. PMID 14613369 DOI: 10.18553/jmcp.2003.9.1.87  1
2002 Shaya FT, Mullins CD, Wong W. Incidence versus prevalence modeling in pharmacoeconomics. Expert Review of Pharmacoeconomics & Outcomes Research. 2: 435-42. PMID 19807467 DOI: 10.1586/14737167.2.5.435  1
2002 Shaya FT, Mullins CD, Wong W, Cho J. Discontinuation rates of topical glaucoma medications in a managed care population. The American Journal of Managed Care. 8: S271-7. PMID 12188170  1
Show low-probability matches.